Hunter Gillies Email

Chief Medical Officer . Aerovate Therapeutics

Boston, MA

Location

LinkedIn

Current Roles

Employees:
29
Revenue:
$2.8M
About
Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease. Aerovate's lead program is a potentially disease modifying drug, AV-101, for people who suffer from pulmonary arterial hypertension (PAH).
Aerovate Therapeutics Address
Boston, MA 02116, US
Boston, MA
United States
Aerovate Therapeutics Email